Rubius Therapeutics Inc
(RUBY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -141,526 | -92,510 | -42,330 | -167,731 | -127,192 |
| Depreciation Amortization | 4,331 | 3,012 | 1,496 | 5,691 | 5,176 |
| Accounts payable and accrued liabilities | 2,773 | -171 | -757 | -1,369 | 2,095 |
| Other Working Capital | 1,708 | -3,117 | -7,301 | 112 | -227 |
| Other Operating Activity | 24,809 | 19,327 | 10,153 | 35,649 | 23,048 |
| Operating Cash Flow | $-107,905 | $-73,459 | $-38,739 | $-127,648 | $-97,100 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -122,671 | -122,671 |
| PPE Investments | -2,280 | -1,591 | -748 | -5,497 | -4,467 |
| Sale Of Investment | 85,000 | 70,000 | 42,500 | 228,600 | 181,102 |
| Investing Cash Flow | $82,720 | $68,409 | $41,752 | $100,432 | $53,964 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 25,000 | 25,000 |
| Common Stock Issued | 10,547 | 9,628 | 5,908 | 1,484 | 1,412 |
| Other Financing Activity | 187,490 | 187,490 | 188,000 | 0 | 0 |
| Financing Cash Flow | $198,037 | $197,118 | $193,908 | $26,484 | $26,412 |
| Beginning Cash Position | 92,901 | 92,901 | 92,901 | 93,633 | 93,633 |
| End Cash Position | 265,753 | 284,969 | 289,822 | 92,901 | 76,909 |
| Net Cash Flow | $172,852 | $192,068 | $196,921 | $-732 | $-16,724 |
| Free Cash Flow | |||||
| Operating Cash Flow | -107,905 | -73,459 | -38,739 | -127,648 | -97,100 |
| Capital Expenditure | -2,280 | -1,591 | -748 | -5,497 | -4,467 |
| Free Cash Flow | -110,185 | -75,050 | -39,487 | -133,145 | -101,567 |